Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin in Secondary Progressive Multiple Sclerosis
NCT03387670Phase 3Completed
- Sponsor
- University College London
- Start
- Mar 2018
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of simvastatin in secondary-progressive multiple sclerosis (SPMS), sponsored by University College London. Started Mar 2018; status: completed.
02
Drugs
simvastatin
03
Conditions
secondary-progressive multiple sclerosis (SPMS)
Beyond the preview
Go deeper on NCT03387670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03387670.